Clinical Trials in Arizona

Showing 5481-5500 of 16,770 trials

HIFEM and Radiofrequency for Muscular System Function Improvement

NCT06703749

The goal of this clinical trial is to investigate the effect of the BTL-899M device on muscular system function in adult subjects seeking treatment for improving their muscular system function in the lower extremities. The main question it aims to answer is: Whether the BTL-899M device is effective for muscular system function improvement 3 months posttreatment compared to the sham group, based on the dynamometer measurement. Researchers will compare a sham group to see if the device is effective. Participants will complete four treatment visits and two follow-up visits. Their strength will be recorded via a dynamometer.

Muscle DamageMuscle StrengthMuscle Weakness

BTL Industries Ltd.33 participantsStarted Apr 2024

Scottsdale, Arizona, United States • Greenwood Village, Colorado, United States • Palm Beach Gardens, Florida, United States

COMPLETEDPhase 131 miles

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

NCT02143401

This phase I trial studies the side effects and the best dose of navitoclax when given together with sorafenib tosylate in treating patients with solid tumors that have returned (relapsed) or do not respond to treatment (refractory). Navitoclax and sorafenib tosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

CirrhosisHepatitis B InfectionHepatitis C Infection+6 more

National Cancer Institute (NCI)29 participantsStarted Jan 2015

Scottsdale, Arizona, United States • Sacramento, California, United States • Aurora, Colorado, United States +7 more locations

HIFEM and Radiofrequency for Muscular System Function Improvement

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Find Trials by Condition in Arizona

FPA150 in Patients With Advanced Solid Tumors

Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction

Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.

Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component

Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Analysis of Both Sex and Device Specific Factors on Outcomes in Patients with Non-Ischemic Cardiomyopathy

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)

PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA)

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Pegtibatinase As an Enzyme Therapy for Patients with Homocystinuria Caused by Cystathionine Beta-Synthase Deficiency (COMPOSE)

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment

VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems

Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery

Third Enhanced Control of Hypertension and Thrombectomy Stroke Domain Within ACT-GLOBAL Adaptive Platform Trial